Pramipexol "neuraxpharm" 0,18 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "neuraxpharm" 0,18 mg tabletter

neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,18 mg

Pramipexol "neuraxpharm" 0,35 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "neuraxpharm" 0,35 mg tabletter

neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg

Pramipexol "neuraxpharm" 0,7 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "neuraxpharm" 0,7 mg tabletter

neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg

Pramipexol "neuraxpharm" 1,1 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "neuraxpharm" 1,1 mg tabletter

neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 1,1 mg

Pramipexol "neuraxpharm" 0,088 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "neuraxpharm" 0,088 mg tabletter

neuraxpharm arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,088 mg

Dimethyl fumarate Neuraxpharm 유럽 연합 - 덴마크어 - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.